Persons tested for SAR-CoV-2 at a military treatment facility in Hawaii.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 09 11 2021
accepted: 19 01 2022
entrez: 4 2 2022
pubmed: 5 2 2022
medline: 22 2 2022
Statut: epublish

Résumé

Health inequalities based on race are well-documented, and the COVID-19 pandemic is no exception. Despite the advances in modern medicine, access to health care remains a primary determinant of health outcomes, especially for communities of color. African-Americans and other minorities are disproportionately at risk for infection with COVID-19, but this problem extends beyond access alone. This study sought to identify trends in race-based disparities in COVID-19 in the setting of universal access to care. Tripler Army Medical Center (TAMC) is a Department of Defense Military Treatment Facility (DoD-MTF) that provides full access to healthcare to active duty military members, beneficiaries, and veterans. We evaluated the characteristics of individuals diagnosed with SARS-CoV-2 infection at TAMC in a retrospective, case-controlled (1:1) study. Most patients (69%) had received a COVID-19 test within 3 days of symptom onset. Multivariable logistic regression analyses were used to identify factors associated with testing positive and to estimate adjusted odds ratios. African-American patients and patients who identified as "Other" ethnicities were two times more likely to test positive for SARS-CoV-2 relative to Caucasian patients. Other factors associated with testing positive include: younger age, male gender, previous positive test, presenting with >3 symptoms, close contact with a COVID-19 positive patient, and being a member of the US Navy. African-Americans and patients who identify as "Other" ethnicities had disproportionately higher rates of positivity of COVID-19. Although other factors contribute to increased test positivity across all patient populations, access to care does not appear to itself explain this discrepancy with COVID-19.

Identifiants

pubmed: 35120186
doi: 10.1371/journal.pone.0263472
pii: PONE-D-21-35130
pmc: PMC8815911
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0263472

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PM R. 2020 Oct;12(10):1009-1014
pubmed: 32700434
Ann Surg. 2020 Dec;272(6):919-924
pubmed: 33021367
Cell Metab. 2021 Mar 2;33(3):479-498
pubmed: 33529600

Auteurs

Javier Barranco-Trabi (J)

Department of Internal Medicine, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Stephen Morgan (S)

Department of Infectious Control, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Seema Singh (S)

Department of Infectious Control, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Jimmy Hill (J)

Department of Infectious Control, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Alexander Kayatani (A)

Department of Microbiology, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Victoria Mank (V)

Department of Internal Medicine, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Holly Nesmith (H)

Department of Family Medicine, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Heather Omara (H)

Department of Family Medicine, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Louis Tripoli (L)

Department of Internal Medicine, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Michael Lustik (M)

Department of Clinical Investigation, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Jennifer Masel (J)

Department of Infectious Disease, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Sharon Chi (S)

Department of Infectious Disease, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Viseth Ngauy (V)

Department of Infectious Disease, Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH